Skip to content

Postoperative Analgesia After Total Hip Replacement

Postoperative Analgesia After Total Hip Replacement

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00219921
Enrollment
120
Registered
2005-09-22
Start date
2005-09-30
Completion date
2007-02-28
Last updated
2007-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Replacement

Keywords

total hip replacement, pain treatment

Brief summary

There are several treatments for postoperative pain after Hip Replacement Surgery. However, some require an intravenous line which may interfere with rehabilitation after surgery. This study aims to evaluate which method of pain treatment is best after Hip Replacement Surgery. Patients will either receive pain treatment at surgery, continuous intravenous pain treatment, or both. In the first two days after surgery, patients will frequently be asked to rate their pain, and use of other pain medication will be monitored.

Detailed description

This is a three-group randomized placebo-controlled double blind trial to assess which postoperative analgesia is best after total hip replacement. The conventional analgesia includes both intrathecal morphine at surgery and Patient Controlled Analgesia (PCA) with morphine in the first 48 hours after surgery. This will be compared with two experimental groups which will receive either intrathecal morphine and PCA with placebo or intrathecal placebo and PCA with morphine. Escape medication with intramuscular morphine is available in all groups. A total of 120 patients will be randomized. VAS- score at rest and with movement will be recorded every three hours for the first 48 hours after surgery, as well as PCA-bolussum and Morphine IM.

Interventions

DRUGIntrathecal morphine at surgery, 0.1mg and placebo
DRUGPatient Controlled Analgesia with iv morphine and placebo
DRUGintrathecal morphine AND patient controlled analgesia with iv morphine

Sponsors

Rijnstate Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
30 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients accepted for fast-track total hip replacement, i.e.ASA 3 or lower

Exclusion criteria

* Not able to speak dutch * communication problems * dementia * mental retardation

Design outcomes

Primary

MeasureTime frame
VAS-score for pain at movement and at rest every three hours
PCA-bolus-sum every three-hour period
Morphine-IM rescue dose every three-hour period

Secondary

MeasureTime frame
quality of physical training
patient satisfaction each 24 hours
urine retention every three hours
PONV every three hours
iv-morphine dose needed to attain VAS-score under 40 mm
itching every three hours
decrease in saturation every three hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026